PTX Price sensitive 19 Nov 2025, 9:02 AM

PTX secures EU Orphan Drug Designation for PTX-100 in CTCL

Prescient Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in